Therapeutic proteins: strategies to modulate their plasma half-lives
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Weinheim, Germany
Wiley-Blackwell, an imprint of John Wiley & Sons
2012
|
| Schlagworte: | |
| Online-Zugang: | FRO01 UBG01 URL des Erstveröffentlichers |
| Beschreibung: | Includes bibliographical references and index For this ready reference, the internationally renowned authority in the field, Roland Kontermann, has assembled a team of outstanding contributors from industry and academia to convey the worldwide knowledge on modifying therapeutic proteins in order to optimize their pharmacological potential. The result is a comprehensive work covering all approaches and aspects of the topic in one handy volume, making this indispensable reading for companies and research institutions working on the development of biopharmaceuticals |
| Beschreibung: | 1 Online-Ressource (374 pages) |
| ISBN: | 128345422X 3527644784 3527644792 3527644806 3527644822 9781283454223 9783527644780 9783527644797 9783527644803 9783527644827 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043394342 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160222s2012 |||| o||u| ||||||eng d | ||
| 020 | |a 128345422X |9 1-283-45422-X | ||
| 020 | |a 3527644784 |c ePub |9 3-527-64478-4 | ||
| 020 | |a 3527644792 |c ePDF |9 3-527-64479-2 | ||
| 020 | |a 3527644806 |c Mobi |9 3-527-64480-6 | ||
| 020 | |a 3527644822 |c oBook |9 3-527-64482-2 | ||
| 020 | |a 9781283454223 |9 978-1-283-45422-3 | ||
| 020 | |a 9783527644780 |c ePub |9 978-3-527-64478-0 | ||
| 020 | |a 9783527644797 |c ePDF |9 978-3-527-64479-7 | ||
| 020 | |a 9783527644803 |c Mobi |9 978-3-527-64480-3 | ||
| 020 | |a 9783527644827 |c oBook |9 978-3-527-64482-7 | ||
| 024 | 7 | |a 10.1002/9783527644827 |2 doi | |
| 035 | |a (ZDB-35-WIC)ocn779616898 | ||
| 035 | |a (OCoLC)779616898 | ||
| 035 | |a (DE-599)BVBBV043394342 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-861 | ||
| 082 | 0 | |a 615.3 |2 23 | |
| 084 | |a VX 8550 |0 (DE-625)147830:253 |2 rvk | ||
| 245 | 1 | 0 | |a Therapeutic proteins |b strategies to modulate their plasma half-lives |c edited by Roland Kontermann |
| 264 | 1 | |a Weinheim, Germany |b Wiley-Blackwell, an imprint of John Wiley & Sons |c 2012 | |
| 300 | |a 1 Online-Ressource (374 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a For this ready reference, the internationally renowned authority in the field, Roland Kontermann, has assembled a team of outstanding contributors from industry and academia to convey the worldwide knowledge on modifying therapeutic proteins in order to optimize their pharmacological potential. The result is a comprehensive work covering all approaches and aspects of the topic in one handy volume, making this indispensable reading for companies and research institutions working on the development of biopharmaceuticals | ||
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 7 | |a Protein drugs / Design |2 fast | |
| 650 | 7 | |a Proteins / Therapeutic use |2 fast | |
| 650 | 4 | |a Proteins / pharmacokinetics | |
| 650 | 4 | |a Half-Life | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Protein drugs / Design | |
| 650 | 4 | |a Proteins / Therapeutic use | |
| 650 | 0 | 7 | |a Abbaureaktion |0 (DE-588)4136352-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelstabilität |0 (DE-588)4122835-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Biopharmazie |0 (DE-588)4006890-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Proteine |0 (DE-588)4076388-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Proteine |0 (DE-588)4076388-2 |D s |
| 689 | 0 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 2 | |a Arzneimittelstabilität |0 (DE-588)4122835-2 |D s |
| 689 | 0 | 3 | |a Biopharmazie |0 (DE-588)4006890-0 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 689 | 1 | 0 | |a Proteine |0 (DE-588)4076388-2 |D s |
| 689 | 1 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 1 | 2 | |a Abbaureaktion |0 (DE-588)4136352-8 |D s |
| 689 | 1 | |8 3\p |5 DE-604 | |
| 700 | 1 | |a Kontermann, Roland |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 3-527-32849-1 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-3-527-32849-9 |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527644827 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-35-WIC | ||
| 940 | 1 | |q UBG_PDA_WIC | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028812925 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527644827 |l FRO01 |p ZDB-35-WIC |q FRO_PDA_WIC |x Verlag |3 Volltext | |
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527644827 |l UBG01 |p ZDB-35-WIC |q UBG_PDA_WIC |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175972801445888 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043394342 |
| classification_rvk | VX 8550 |
| collection | ZDB-35-WIC |
| ctrlnum | (ZDB-35-WIC)ocn779616898 (OCoLC)779616898 (DE-599)BVBBV043394342 |
| dewey-full | 615.3 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.3 |
| dewey-search | 615.3 |
| dewey-sort | 3615.3 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03996nmm a2200829zc 4500</leader><controlfield tag="001">BV043394342</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160222s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">128345422X</subfield><subfield code="9">1-283-45422-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527644784</subfield><subfield code="c">ePub</subfield><subfield code="9">3-527-64478-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527644792</subfield><subfield code="c">ePDF</subfield><subfield code="9">3-527-64479-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527644806</subfield><subfield code="c">Mobi</subfield><subfield code="9">3-527-64480-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527644822</subfield><subfield code="c">oBook</subfield><subfield code="9">3-527-64482-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781283454223</subfield><subfield code="9">978-1-283-45422-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527644780</subfield><subfield code="c">ePub</subfield><subfield code="9">978-3-527-64478-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527644797</subfield><subfield code="c">ePDF</subfield><subfield code="9">978-3-527-64479-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527644803</subfield><subfield code="c">Mobi</subfield><subfield code="9">978-3-527-64480-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527644827</subfield><subfield code="c">oBook</subfield><subfield code="9">978-3-527-64482-7</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/9783527644827</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-35-WIC)ocn779616898</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)779616898</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043394342</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-861</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.3</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VX 8550</subfield><subfield code="0">(DE-625)147830:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Therapeutic proteins</subfield><subfield code="b">strategies to modulate their plasma half-lives</subfield><subfield code="c">edited by Roland Kontermann</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Weinheim, Germany</subfield><subfield code="b">Wiley-Blackwell, an imprint of John Wiley & Sons</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (374 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">For this ready reference, the internationally renowned authority in the field, Roland Kontermann, has assembled a team of outstanding contributors from industry and academia to convey the worldwide knowledge on modifying therapeutic proteins in order to optimize their pharmacological potential. The result is a comprehensive work covering all approaches and aspects of the topic in one handy volume, making this indispensable reading for companies and research institutions working on the development of biopharmaceuticals</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Protein drugs / Design</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Proteins / Therapeutic use</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Proteins / pharmacokinetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Half-Life</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein drugs / Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Proteins / Therapeutic use</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Abbaureaktion</subfield><subfield code="0">(DE-588)4136352-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelstabilität</subfield><subfield code="0">(DE-588)4122835-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biopharmazie</subfield><subfield code="0">(DE-588)4006890-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Proteine</subfield><subfield code="0">(DE-588)4076388-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Proteine</subfield><subfield code="0">(DE-588)4076388-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelstabilität</subfield><subfield code="0">(DE-588)4122835-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Biopharmazie</subfield><subfield code="0">(DE-588)4006890-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Proteine</subfield><subfield code="0">(DE-588)4076388-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Abbaureaktion</subfield><subfield code="0">(DE-588)4136352-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kontermann, Roland</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">3-527-32849-1</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-3-527-32849-9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527644827</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-35-WIC</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">UBG_PDA_WIC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028812925</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527644827</subfield><subfield code="l">FRO01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">FRO_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527644827</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">UBG_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV043394342 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:24:47Z |
| institution | BVB |
| isbn | 128345422X 3527644784 3527644792 3527644806 3527644822 9781283454223 9783527644780 9783527644797 9783527644803 9783527644827 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028812925 |
| oclc_num | 779616898 |
| open_access_boolean | |
| owner | DE-861 |
| owner_facet | DE-861 |
| physical | 1 Online-Ressource (374 pages) |
| psigel | ZDB-35-WIC UBG_PDA_WIC ZDB-35-WIC FRO_PDA_WIC ZDB-35-WIC UBG_PDA_WIC |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | Wiley-Blackwell, an imprint of John Wiley & Sons |
| record_format | marc |
| spelling | Therapeutic proteins strategies to modulate their plasma half-lives edited by Roland Kontermann Weinheim, Germany Wiley-Blackwell, an imprint of John Wiley & Sons 2012 1 Online-Ressource (374 pages) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index For this ready reference, the internationally renowned authority in the field, Roland Kontermann, has assembled a team of outstanding contributors from industry and academia to convey the worldwide knowledge on modifying therapeutic proteins in order to optimize their pharmacological potential. The result is a comprehensive work covering all approaches and aspects of the topic in one handy volume, making this indispensable reading for companies and research institutions working on the development of biopharmaceuticals MEDICAL / Pharmacology bisacsh Protein drugs / Design fast Proteins / Therapeutic use fast Proteins / pharmacokinetics Half-Life Medizin Protein drugs / Design Proteins / Therapeutic use Abbaureaktion (DE-588)4136352-8 gnd rswk-swf Arzneimittelstabilität (DE-588)4122835-2 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Biopharmazie (DE-588)4006890-0 gnd rswk-swf Proteine (DE-588)4076388-2 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content Proteine (DE-588)4076388-2 s Arzneimittel (DE-588)4003115-9 s Arzneimittelstabilität (DE-588)4122835-2 s Biopharmazie (DE-588)4006890-0 s 2\p DE-604 Abbaureaktion (DE-588)4136352-8 s 3\p DE-604 Kontermann, Roland Sonstige oth Erscheint auch als Druckausgabe 3-527-32849-1 Erscheint auch als Druckausgabe 978-3-527-32849-9 https://onlinelibrary.wiley.com/doi/book/10.1002/9783527644827 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Therapeutic proteins strategies to modulate their plasma half-lives MEDICAL / Pharmacology bisacsh Protein drugs / Design fast Proteins / Therapeutic use fast Proteins / pharmacokinetics Half-Life Medizin Protein drugs / Design Proteins / Therapeutic use Abbaureaktion (DE-588)4136352-8 gnd Arzneimittelstabilität (DE-588)4122835-2 gnd Arzneimittel (DE-588)4003115-9 gnd Biopharmazie (DE-588)4006890-0 gnd Proteine (DE-588)4076388-2 gnd |
| subject_GND | (DE-588)4136352-8 (DE-588)4122835-2 (DE-588)4003115-9 (DE-588)4006890-0 (DE-588)4076388-2 (DE-588)4143413-4 |
| title | Therapeutic proteins strategies to modulate their plasma half-lives |
| title_auth | Therapeutic proteins strategies to modulate their plasma half-lives |
| title_exact_search | Therapeutic proteins strategies to modulate their plasma half-lives |
| title_full | Therapeutic proteins strategies to modulate their plasma half-lives edited by Roland Kontermann |
| title_fullStr | Therapeutic proteins strategies to modulate their plasma half-lives edited by Roland Kontermann |
| title_full_unstemmed | Therapeutic proteins strategies to modulate their plasma half-lives edited by Roland Kontermann |
| title_short | Therapeutic proteins |
| title_sort | therapeutic proteins strategies to modulate their plasma half lives |
| title_sub | strategies to modulate their plasma half-lives |
| topic | MEDICAL / Pharmacology bisacsh Protein drugs / Design fast Proteins / Therapeutic use fast Proteins / pharmacokinetics Half-Life Medizin Protein drugs / Design Proteins / Therapeutic use Abbaureaktion (DE-588)4136352-8 gnd Arzneimittelstabilität (DE-588)4122835-2 gnd Arzneimittel (DE-588)4003115-9 gnd Biopharmazie (DE-588)4006890-0 gnd Proteine (DE-588)4076388-2 gnd |
| topic_facet | MEDICAL / Pharmacology Protein drugs / Design Proteins / Therapeutic use Proteins / pharmacokinetics Half-Life Medizin Abbaureaktion Arzneimittelstabilität Arzneimittel Biopharmazie Proteine Aufsatzsammlung |
| url | https://onlinelibrary.wiley.com/doi/book/10.1002/9783527644827 |
| work_keys_str_mv | AT kontermannroland therapeuticproteinsstrategiestomodulatetheirplasmahalflives |